UNIVERSITY OF CALIFORNIA, IRVINE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1965-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.uci.edu
Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab
- First Posted Date
- 2006-04-27
- Last Posted Date
- 2018-01-12
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 10
- Registration Number
- NCT00319839
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
Evaluation of Pre-dose and Post-dose Anti-factor Xa Levels With Enoxaparin Use During Pregnancy
Completed
- Conditions
- Pregnancy
- First Posted Date
- 2006-04-27
- Last Posted Date
- 2013-02-08
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 15
- Registration Number
- NCT00319176
- Locations
- 🇺🇸
Long Beach Memorial Medical Center, Long Beach, California, United States
Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor
- First Posted Date
- 2006-04-19
- Last Posted Date
- 2019-02-27
- Lead Sponsor
- University of California, Irvine
- Registration Number
- NCT00315913
- Locations
- 🇺🇸
Long Beach Memorial Medical Center, Long Beach, California, United States
Improving Tumor Oxygenation in Cervical Cancer
Phase 2
Withdrawn
- Conditions
- Cervical Cancer
- First Posted Date
- 2005-11-23
- Last Posted Date
- 2018-12-03
- Lead Sponsor
- University of California, Irvine
- Registration Number
- NCT00257829
Weekly IV Topotecan and Cisplatin With Radiation in Cervical Carcinoma
- First Posted Date
- 2005-11-23
- Last Posted Date
- 2018-02-05
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 12
- Registration Number
- NCT00257816
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
Cellular Immune Augmentation in Colon and Rectal Cancer
- First Posted Date
- 2005-11-22
- Last Posted Date
- 2018-10-31
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 20
- Registration Number
- NCT00257322
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
Capecitabine and Docetaxel in Advanced/Recurrent Cervical Cancer
Phase 2
Completed
- Conditions
- Cervical Cancer
- First Posted Date
- 2005-11-22
- Last Posted Date
- 2013-02-08
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 5
- Registration Number
- NCT00257348
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma
Phase 2
Terminated
- Conditions
- Gastric CarcinomaGastroesophageal Junction Carcinoma
- Interventions
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2019-02-08
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 4
- Registration Number
- NCT00256321
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
Resveratrol for Patients With Colon Cancer
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2014-06-20
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 11
- Registration Number
- NCT00256334
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma
Phase 2
Terminated
- Conditions
- Gastroesophageal CancerEsophageal Cancer
- Interventions
- First Posted Date
- 2005-11-21
- Last Posted Date
- 2018-01-26
- Lead Sponsor
- University of California, Irvine
- Target Recruit Count
- 4
- Registration Number
- NCT00256269
- Locations
- 🇺🇸
Chao Family Comprehensive Cancer Center, Orange, California, United States
© Copyright 2025. All Rights Reserved by MedPath